Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
- PMID: 27387551
- PMCID: PMC4936197
- DOI: 10.1186/s12967-016-0958-x
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
Abstract
Background: BRAF is the most frequently mutated gene in differentiated thyroid cancer (DTC). Previous studies on DTC have well documented high rates of the BRAF (V600E) mutation in patients of mixed ages. Previous studies either included a mix of pediatric and adult patients or pediatric patients only. However, the prevalence of hotspot and non-hotspot BRAF mutations and its significance in pure adult DTCs is not yet well determined. In this study we determine the frequency of this classical BRAF mutation and other rare BRAF mutations in pure adult DTCs.
Methods: A total of 204 adult DTC samples (Age >18 years) were analyzed for mutations in exon 15 of the BRAF gene by performing polymerase chain reaction (PCR) amplification of tumor genomic DNAs and direct sequencing of amplicons using Sanger sequencing. Obtained results were correlated to clinical and pathological characteristics of DTCs. Statistical analyses were performed using SPSS (The Statistical Package for Social Sciences) version 20 software.
Results: Overall, BRAF mutations were identified in 48.5 % (99/204) of adult DTCs. Three rare non-hotspot mutations (T599I, T599dup and K601E) were detected in four tumor samples (2 %). One (K601E) of these non-hotspot mutations occurred in conventional papillary thyroid cancer (CPTC) and other three (T599I, T599dup and K601E) were found in follicular variant PTC. We found significant association between BRAF (V600E) mutation and age (P < 0.0001), extrathyroidal invasion (P = 0.017), lymph node metastasis (P = 0.038) and TNM stage III/IV (P = 0.001).
Conclusions: Our study is the first to report BRAF mutations in a pure adult sample of DTCs of Saudi Arabian ethnicity. Our results show a high rate and a strong prognostic role of the classical BRAF (V600E) mutation and also suggest a common occurrence of non-hot spot mutations in adult DTC from this highly inbred population.
Keywords: BRAF; DTC; Mutation; Oncogene; PTC; Saudi Arabia; Thyroid cancer.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4936197/bin/12967_2016_958_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4936197/bin/12967_2016_958_Fig2_HTML.gif)
Similar articles
-
Single Point Mutations in Pediatric Differentiated Thyroid Cancer.Thyroid. 2017 Feb;27(2):189-196. doi: 10.1089/thy.2016.0339. Epub 2016 Dec 20. Thyroid. 2017. PMID: 27824297
-
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.J Clin Endocrinol Metab. 2007 Nov;92(11):4085-90. doi: 10.1210/jc.2007-1179. Epub 2007 Sep 4. J Clin Endocrinol Metab. 2007. PMID: 17785355
-
Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.Thyroid. 2016 Feb;26(2):242-7. doi: 10.1089/thy.2015.0227. Epub 2015 Dec 17. Thyroid. 2016. PMID: 26422023
-
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.Cancer. 2005 Jun 1;103(11):2261-8. doi: 10.1002/cncr.21073. Cancer. 2005. PMID: 15880523 Review.
-
Application of molecular biology of differentiated thyroid cancer for clinical prognostication.Endocr Relat Cancer. 2016 Nov;23(11):R499-R515. doi: 10.1530/ERC-16-0372. Epub 2016 Aug 30. Endocr Relat Cancer. 2016. PMID: 27578827 Review.
Cited by
-
LncRNA GAS8-AS1 dinucleotide genetic variantn.713A>G, n.714T>C is associated with early-stage disease, lymph node, and distant metastasis in differentiated thyroid cancer.Endocrine. 2024 Apr 5. doi: 10.1007/s12020-024-03802-7. Online ahead of print. Endocrine. 2024. PMID: 38580894
-
Expression of RASSF1A, DIRAS3, and AKAP9 Genes in Thyroid Lesions: Implications for Differential Diagnosis and Prognosis of Thyroid Carcinomas.Int J Mol Sci. 2024 Jan 1;25(1):562. doi: 10.3390/ijms25010562. Int J Mol Sci. 2024. PMID: 38203733 Free PMC article.
-
How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?Front Endocrinol (Lausanne). 2023 Oct 4;14:1270796. doi: 10.3389/fendo.2023.1270796. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37859987 Free PMC article.
-
Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas.Br J Biomed Sci. 2022 Jan 31;79:10208. doi: 10.3389/bjbs.2021.10208. eCollection 2022. Br J Biomed Sci. 2022. PMID: 35996504 Free PMC article.
-
Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers.Mol Clin Oncol. 2021 Oct;15(4):210. doi: 10.3892/mco.2021.2373. Epub 2021 Aug 10. Mol Clin Oncol. 2021. PMID: 34462665 Free PMC article.
References
-
- Pathology and genetics of tumours of endocrine organs. In: IARC WHO classification of tumours. World Health Organization; 2004.
-
- National Cancer Registry. Riyadh: 2007.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials